Associations Between Vascular Risk Factor Levels and Cognitive Decline Among Stroke Survivors
JAMA Network Open · 17.05.2023 · 6 (5) · e2313879
DOI: 10.1001/jamanetworkopen.2023.13879 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JAMA Network Open, online erschienen am 17.05.2023. Verfasst von Deborah A Levine und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Stroke. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, Department of Health.
Themen: Schlaganfall
Abstract (Originalsprache)
Importance Incident stroke is associated with accelerated cognitive decline. Whether poststroke vascular risk factor levels are associated with faster cognitive decline is uncertain.
Objective
To evaluate associations of poststroke systolic blood pressure (SBP), glucose, and low-density lipoprotein (LDL) cholesterol levels with cognitive decline. Design, Setting, and Participants Individual participant data meta-analysis of 4 US cohort studies (conducted 1971-2019). Linear mixed-effects models estimated changes in cognition after incident stroke. Median (IQR) follow-up was 4.7 (2.6-7.9) years. Analysis began August 2021 and was completed March 2023. Exposures Time-dependent cumulative mean poststroke SBP, glucose, and LDL cholesterol levels. Main Outcomes and Measures The primary outcome was change in global cognition. Secondary outcomes were change in executive function and memory. Outcomes were standardized as t scores (mean [SD], 50 [10]); a 1-point difference represents a 0.1-SD difference in cognition.
Results
A total of 1120 eligible dementia-free individuals with incident stroke were identified; 982 (87.7%) had available covariate data and 138 (12.3%) were excluded for missing covariate data. Of the 982, 480 (48.9%) were female individuals, and 289 (29.4%) were Black individuals. The median age at incident stroke was 74.6 (IQR, 69.1-79.8; range, 44.1-96.4) years. Cumulative mean poststroke SBP and LDL cholesterol levels were not associated with any cognitive outcome. However, after accounting for cumulative mean poststroke SBP and LDL cholesterol levels, higher cumulative mean poststroke glucose level was associated with faster decline in global cognition (−0.04 points/y faster per each 10–mg/dL increase [95% CI, −0.08 to −0.001 points/y]; P = .046) but not executive function or memory. After restricting to 798 participants with apolipoprotein E4 (APOE4) data and controlling for APOE4 and APOE4 × time, higher cumulative mean poststroke glucose level was associated with a faster decline in global cognition in models without and with adjustment for cumulative mean poststroke SBP and LDL cholesterol levels (−0.05 points/y faster per 10–mg/dL increase [95% CI, −0.09 to −0.01 points/y]; P = .01; −0.07 points/y faster per 10–mg/dL increase [95% CI, −0.11 to −0.03 points/y]; P = .002) but not executive function or memory declines. Conclusions and Relevance In this cohort study, higher poststroke glucose levels were associated with faster global cognitive decline. We found no evidence that poststroke LDL cholesterol and SBP levels were associated with cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Cognitive Health Services Research Program, University of Michigan, Ann Arbor.
- Department of Neurology and Stroke Program, University of Michigan, Ann Arbor.
- Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
- Department of Nursing, University of Michigan, Ann Arbor.
- Department of Biostatistics, University of Michigan, Ann Arbor.
- Department of Epidemiology, Johns Hopkins Bloomberg School Public Health, Baltimore, Maryland.
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- Department of Health
- NIDDK NIH HHS
- NINDS NIH HHS
Zitieren
APA
Levine, D. A., Chen, B., Galecki, A. T., Gross, A. L., Briceño, E. M., Whitney, R. T., Ploutz-Snyder, R. J., Giordani, B. J., Sussman, J. B., Burke, J. F., Lazar, R. M., Howard, V. J., Aparicio, H. J., Beiser, A. S., Elkind, M. S. V., Gottesman, R. F., Koton, S., Pendlebury, S. T., Sharma, A., …, & Hayward, R. A. (2023). Associations Between Vascular Risk Factor Levels and Cognitive Decline Among Stroke Survivors. JAMA Network Open, 6(5), e2313879. https://doi.org/10.1001/jamanetworkopen.2023.13879
Vancouver
Levine DA, Chen B, Galecki AT, Gross AL, Briceño EM, Whitney RT, et al. Associations Between Vascular Risk Factor Levels and Cognitive Decline Among Stroke Survivors. JAMA Network Open. 2023;6(5):e2313879. doi:10.1001/jamanetworkopen.2023.13879
BibTeX
@article{Levine2023,
author = {Levine, Deborah A and Chen, Bingxin and Galecki, Andrzej T and Gross, Alden L and Briceño, Emily M and Whitney, Rachael T and Ploutz-Snyder, Robert J and Giordani, Bruno J and Sussman, Jeremy B and Burke, James F and Lazar, Ronald M and Howard, Virginia J and Aparicio, Hugo J and Beiser, Alexa S and Elkind, Mitchell S V and Gottesman, Rebecca F and Koton, Silvia and Pendlebury, Sarah T and Sharma, Anu and Springer, Mellanie V and Seshadri, Sudha and Romero, Jose R and Hayward, Rodney A},
title = {Associations Between Vascular Risk Factor Levels and Cognitive Decline Among Stroke Survivors},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {5},
pages = {e2313879},
doi = {10.1001/jamanetworkopen.2023.13879}
}
EUVIMED